Oncology

Latest News

Doctor showing lung x ray | Image credit: didesign – stock.adobe.com
Tarlatamab Safety Varies Between Clinical and Real-World SCLC Trials

May 6th 2025

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung cancer (SCLC), but it was also linked to higher rates of serious adverse events like cytokine release syndrome than seen in clinical trials.

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com
COA 2025: Insight, Innovation, and Independent Strength

May 5th 2025

COA logo | Image Credit: © Amy Kinnamon
Community Oncology Reacts to Trump's Drug Pricing Executive Order

May 2nd 2025

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com
5 Things You Should Know About Skin Cancer

May 2nd 2025

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com
Patient Navigation Is Nonnegotiable in Cancer Care

May 1st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Innovative Technology and Healthcare Costs
November 24th 2016

Innovative Technology and Healthcare Costs

Importance of Data Sharing in Healthcare
November 24th 2016

Importance of Data Sharing in Healthcare

Leveraging Health IT in Cancer Care
November 24th 2016

Leveraging Health IT in Cancer Care

Who Shares the Maximum Risk With Innovative Treatments in Oncology?
November 24th 2016

Who Shares the Maximum Risk With Innovative Treatments in Oncology?

Site of Service and the Challenge of Value-Based Care
November 24th 2016

Site of Service and the Challenge of Value-Based Care

Risk-Based Contracting in Oncology
November 24th 2016

Risk-Based Contracting in Oncology

Benefits of a Medical Home Model in Oncology
November 24th 2016

Benefits of a Medical Home Model in Oncology

Population Health and APMs
November 24th 2016

Population Health and APMs

Is the Oncology Care Model Patient Centered?
November 24th 2016

Is the Oncology Care Model Patient Centered?

Value-Based Care and APMs in Oncology: A Payer Perspective
November 24th 2016

Value-Based Care and APMs in Oncology: A Payer Perspective

Adapting and Paying for Value-Based Care
November 24th 2016

Adapting and Paying for Value-Based Care

Defining Alternative Payment Models
November 24th 2016

Defining Alternative Payment Models

Site Logo
November 23rd 2016

Another Death Reported in Juno's CAR-T Trial in Patients With ALL

AJMC Staff
Within 4 months of the last reported incident, Juno Therapeutics has again halted the phase 2 “Rocket” trial of JCAR015 in patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).
Site Logo
November 23rd 2016

5 Key Highlights From the Patient-Centered Oncology Care Meeting

Surabhi Dangi-Garimella, PhD
Here's a glimpse into what The American Journal of Managed Care’s 5th annual Patient-Centered Oncology Care® meeting had in store for its attendees.
Dr Robert Carlson Predicts 2017 Will Be "Year of Uncertainty" For Healthcare
November 23rd 2016

Dr Robert Carlson Predicts 2017 Will Be "Year of Uncertainty" For Healthcare

There is significant uncertainty surrounding the healthcare system’s future in 2017 under a Republican Congress and President, but it’s unlikely that the Affordable Care Act will be repealed without some replacement that accommodates the individuals newly covered by it, said Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network.
PCOC16: Panel Discussion on the Future of Oncology Care
November 23rd 2016

PCOC16: Panel Discussion on the Future of Oncology Care

The 5th Annual Patient-Centered Oncology Care Meeting closed out with a panel discussion with an eye on the future. Donald Trump's surprise election has caused turmoil in the healthcare industry as the Affordable Care Act seems certain to be repealed at least in part. However, the move to value-based care will likely continue as planned.
This Week in Managed Care: November 23, 2016
November 23rd 2016

This Week in Managed Care: November 23, 2016

This week, the top managed care stories included the FDA's approval of rival combination therapies for type 2 diabetes, the American Medical Association issued mHealth guidelines, and a study found the dementia rate declining.
Debra Madden: Oncologists Should Anticipate Patient Concerns About Immunotherapy
November 23rd 2016

Debra Madden: Oncologists Should Anticipate Patient Concerns About Immunotherapy

When helping cancer patients decide if immuno-oncology treatments are right for them, clinicians should not focus only on the potential risks and benefits, said Debra L. Madden, cancer research advocate and patient representative. Oncologists should ensure patients are aware of the variable responses to the therapy, like the phenomenon of pseudoprogression.
Site Logo
November 23rd 2016

PCOC16: Integrating Patient-Centered Outcomes in APMs

Surabhi Dangi-Garimella, PhD
At the 5th annual Patient-Centered Oncology Care® meeting in Baltimore, Maryland, moderator Bruce Feinberg, DO, was joined by a care provider, a payer, and a community oncology representative to discuss efforts that maintain the patient at the core of payment models.
Site Logo
November 23rd 2016

Lung Cancer Screening Reveals How Deadly Smoking Is for Those With Diabetes

Mary Caffrey
While smoking has long been known to aggravate diabetes, the new study shows just how deadly the habit is for those with the chronic condition.
Site Logo
November 22nd 2016

PCOC16: "Oncology Care 2017" Panel Discusses Future of Cancer Care

Christina Mattina
The 5th annual Patient-Centered Oncology Care® (PCOC) meeting, hosted by The American Journal of Managed Care, November 17-18, in Baltimore, Maryland, concluded with a panel discussion on the future of oncology care in 2017. The panelists concurred that value-based payment is here to stay despite the imminent changes in healthcare.
Site Logo
November 22nd 2016

PCOC16: Unraveling the Value in Oncology Care for the Payer

Surabhi Dangi-Garimella, PhD
At the 5th annual Patient-Centered Oncology Care® meeting, Roy Beveridge, MD, senior vice president and chief medical officer at Humana, walked the audience through the healthcare world’s transition to value-based care and explained why payers have faith in this transition.
Site Logo
November 22nd 2016

Do We Need to Realign Evidence-Based Versus Precision Medicine?

Debra Madden
An interview with geneticist and pathologist Gabriel Bien-Willner, MD, PhD, FCAP, on why we need to change our outlook toward precision medicine in oncology.
Dr Roy Beveridge: Value-Based Care Brings Caregivers Together
November 21st 2016

Dr Roy Beveridge: Value-Based Care Brings Caregivers Together

Value-based care in oncology will be a great thing for patients because it will bring the caregivers together, said Roy Beveridge, MD, chief medical officer of Humana and the keynote speaker at Patient-Centered Oncology Care.
Site Logo
November 21st 2016

Catching Them Early: Outreach Program Could Avert HCC in Cirrhosis Patients

Surabhi Dangi-Garimella, PhD
A prospective trial that reached out to patients with cirrhosis to undergo an ultrasound screen found that the outreach effort doubled the percentage of patients who were screened for hepatocellular carcinoma.
Site Logo
November 21st 2016

Little Patient Benefit to Using G-CSF to Prevent Neutropenia

Laura Joszt, MA
There is little patient benefit to using granulocyte colony-stimulating factor (G-CSF) to help white blood cell growth and reduce the risk of infection in women with breast cancer, according to a study published in Journal of Clinical Oncology.
Site Logo
November 21st 2016

PCOC16: Immuno‐Oncology Agents in a World of Precision Medicine

Surabhi Dangi-Garimella, PhD
At the 5th annual meeting of Patient-Centered Oncology Care®, hosted by The American Journal of Managed Care, November 17-18 in Baltimore, Maryland, experts with diverse experiences and backgrounds discussed the contradiction presented by immuno-oncology agents in the world of precision medicine.
Site Logo
November 20th 2016

End of ACA Won't Stop March Toward Value-Based Care, Experts Say

President-elect Donald J. Trump’s upset win almost certainly means the end of the Affordable Care Act (ACA) as we know it, but experts who spoke at Patient-Centered Oncology Care Thursday and Friday said the movement toward value-based payment will continue. The fifth annual meeting, presented by The American Journal of Managed Care, took place in Baltimore, Maryland.
This Week in Managed Care: November 19, 2016
November 19th 2016

This Week in Managed Care: November 19, 2016

This week, the top managed care news included president-elect Donald Trump outlining parts of Obamacare he would be willing to keep, lawmakers confirming they still want to pass the 21st Century Cures Act, and the FDA held a 2-day hearing on off-label use.
Dr Bruce Feinberg: PCOC Has the Greatest Depth and Breadth
November 19th 2016

Dr Bruce Feinberg: PCOC Has the Greatest Depth and Breadth

What makes Patient-Centered Oncology Care stand out from other meetings is the equal representation among all stakeholders, which gives the meeting a unique depth, said Bruce Feinberg, DO, vice president and chief medical officer at Cardinal Health Specialty Solutions.
<1
...
868788899091929394
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo